...formance, 5 ml. The same high performance streptav... fast, reliable purification of biotinylated compo.../20, or other columns when larger scale purificati...ither the strong interactions of biotin and strept...
Rabbit Anti-Human SENP1 Monoclonal Antibody, Clone ZMD.366 from Invitrogen
Agar from Calbiochem
STP3, T7 from Novagen
Biology Products:(Date:12/4/2009)...ewswire/ -- Stemline Therapeutics, Inc. today anno...L-3R targeting agents, SL-401 and SL-501, in both ...oid leukemia (CML) have been selected for poster p... the American Society of Hematology (ASH), to be h...ster will be presented by Stemline,s collaborators...
(Date:12/3/2009)...PRNewswire-FirstCall/ -- VIA Pharmaceuticals, Inc.... on the development of compounds for the treatment...nounced that it has completed the last patient vis...91. ,, The FDG-PET trial enrolled 52 patients ...nada including Massachusetts General Hospital, Mou...
(Date:12/3/2009)...ndia, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang,...ike Biotechnology Co. Ltd.,( http://www.beikebiote...etic,Foot Care in New Delhi, India, November 22, 2...nd regenerative medicine company. , The c...ation (IPA), aimed,to help podiatrists and researc...
(Date:12/2/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Drug Discovery Technologies - A Glob..., http://www.reportlinker.com/p0164246/Drug-Dis...ends--Opportunities.html ,, Drug discovery has...harmaceutical company,s business strategy. There a...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9